AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)
Clinical trial NCT01360255 · COMPLETED
Trial details
- NCT number
- NCT01360255
- Sponsor
- University Hospital Freiburg
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-05-01
- Primary completion
- 2015-11-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.